Funds and ETFs McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
559.9 USD +0.86% Intraday chart for McKesson Corporation +5.87% +20.94%

ETFs positioned on McKesson Corporation

Name Weight AuM 1st Jan change Investor Rating
0.06% 0 M€ +5.79% -
0.06% 0 M€ +5.63% -
0.05% 1 M€ +3.03% -
0.05% 2 M€ +3.16% -
0.05% 0 M€ +0.34% -
0.04% 414 M€ +11.90% -
0.04% 1,006 M€ -.--%
0.04% 0 M€ +4.20% -
0.04% 29 M€ -.--% -
0.04% 322 M€ +13.88%
0.04% 0 M€ +3.50% -
0.03% 6 M€ +3.89%
0.03% 0 M€ +2.80% -
0.03% 0 M€ -0.73% -
0.03% 0 M€ +2.72% -
0.03% 284 M€ -.--%
0.02% 7 M€ +0.11% -
0.02% 0 M€ +11.98% -
0.02% 0 M€ +0.32% -
0.02% 0 M€ +0.50% -
0.01% 15 M€ -1.62% -
0.01% 0 M€ +3.95% -
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
559.9 USD
Average target price
579.9 USD
Spread / Average Target
+3.57%
Consensus
  1. Stock Market
  2. Equities
  3. MCK Stock
  4. Funds and ETFs McKesson Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW